- Alemtuzumab2014 | First Faculty of Medicine
- Alemtuzumab in current clinical practice2016 | First Faculty of Medicine
- Alemtuzumab in the treatment of sclerosis multiplex2017 | Faculty of Medicine in Hradec Králové
- Alemtuzumab in multiple sclerosis treatment2015 | Second Faculty of Medicine
- Alemtuzumab treatment in multiple slerosis: real clinical experience2019 | Faculty of Medicine in Hradec Králové
- Guidelines for alemtuzumab treatment in chronic lymphocytic leukemia (CLL)2012 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Alemtuzumab in the therapy of patients with relapsing-remitting multiple sclerosis2016 | First Faculty of Medicine
- Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective2017 | Third Faculty of Medicine
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders2017 | Second Faculty of Medicine
- Highly active relapse / reminent multiple sclerosis and okrelizumab after failure of alemtuzumab treatment2020 | Faculty of Medicine in Hradec Králové
- Alemtuzumab by refracting ANCA-associated vasculiltis2012 | First Faculty of Medicine
- Ofatumumab treatment of fludarabine and alemtuzumab refractory patients2012 | Faculty of Medicine in Hradec Králové
- Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?2008 | First Faculty of Medicine
- Elevated D-dimer as an immediate response to alemtuzumab treatment2021 | Second Faculty of Medicine
- Alemtuzumab In Relapsing And Refractory Chronic Lymphocytic Leukemia. A single Centre ExperiencePublication without faculty affiliation
- Alemtuzumab and intrathecal methotrexate failed in the therapy of Rasmussen encephalitis2017 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis2013 | Third Faculty of Medicine
- Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 20152015 | First Faculty of Medicine
- Rapid achievement of complete remission using alemtuzumab in a patient with refractory Sézary syndrome2007 | Faculty of Medicine in Hradec Králové
- Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients2016 | First Faculty of Medicine
- Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy2020 | Faculty of Medicine in Hradec Králové
- Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use2015 | First Faculty of Medicine
- Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program2017 | First Faculty of Medicine, Second Faculty of Medicine
- Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?2008 | Faculty of Medicine in Hradec Králové
- Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses2017 | First Faculty of Medicine
- Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis2019 | First Faculty of Medicine
- Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies2023 | First Faculty of Medicine
- Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up2022 | First Faculty of Medicine
- Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study2019 | First Faculty of Medicine